Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.39 USD | +2.39% | +5.68% | +1.38% |
May. 13 | Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test | MT |
May. 13 | Qiagen Obtains US FDA Clearance for Respiratory Syndromic Testing Panel | MT |
Financials (USD)
Sales 2024 * | 2.01B | Sales 2025 * | 2.14B | Capitalization | 9.83B |
---|---|---|---|---|---|
Net income 2024 * | 404M | Net income 2025 * | 450M | EV / Sales 2024 * | 5.06 x |
Net Debt 2024 * | 325M | Net cash position 2025 * | 206M | EV / Sales 2025 * | 4.5 x |
P/E ratio 2024 * |
24.3
x | P/E ratio 2025 * |
21.8
x | Employees | 5,900 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.67% |
Latest transcript on Qiagen N.V.
1 day | +2.39% | ||
1 week | +5.68% | ||
Current month | +7.23% | ||
1 month | +14.42% | ||
3 months | +5.85% | ||
6 months | +11.32% | ||
Current year | +1.38% |
Managers | Title | Age | Since |
---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 60 | 15-01-31 |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Roland Sackers
DFI | Director of Finance/CFO | 56 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 11-05-31 | |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Lawrence Rosen
CHM | Chairman | 66 | 13-06-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.10% | 1 M€ | -2.17% | - | |
1.79% | 2 M€ | -.--% | ||
1.65% | 2 M€ | +9.27% | ||
1.32% | 144 M€ | +1.44% | - | |
1.08% | 8 M€ | +4.88% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 45.39 | +2.39% | 837,427 |
24-05-13 | 44.33 | +1.65% | 801,850 |
24-05-10 | 43.61 | +0.07% | 655,246 |
24-05-09 | 43.58 | +1.49% | 675,307 |
24-05-08 | 42.94 | -0.02% | 1,097,280 |
Delayed Quote Nyse, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.38% | 9.83B | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- QGEN Stock